Navigation Links
Alchem International Opens Sales and Marketing Office in the U.S.
Date:2/1/2012

MINNEAPOLIS, February 1, 2012 /PRNewswire/ --

Alchem International Ltd. opens its first North American office in Minneapolis. The sales and marketing office will be spearheaded by Laurent Leduc, former Vice President of Frutarom Health, Inc. This office will cater to the rapidly growing demand in North America for GMP manufacturers of extracts and their purified derivatives for the supplement, pharmaceutical and cosmetic industries.

Alchem International Ltd. is the largest manufacturer of extracts and their purified derivatives in India. Approved by the U.S. FDA, the company has three facilities that comply with international GMP standards. Alchem manufactures herbal extracts and pure pharmaceuticals that conform to USP and other international standards. Its ingredient offerings include natural extracts such as vinpocetine, Coleus Forskolin, sennosides and quinine. Alchem prides itself on its product quality, customer satisfaction and commitment to the environment.

Born in France, Leduc began his international career at Sandoz/Novartis in Minneapolis. In 1995, he led the creation of Acatris Health. Leduc's vast experience includes the release of innovative branded ingredients and proprietary blends.

"I'm very excited about opening Alchem's first North American office and welcome the opportunity to offer to the supplement and cosmetic industries premium quality ingredients and formulations supported by science," says Leduc. "My role will be to introduce the region to Alchem and its portfolio of high-quality ingredients, and to increase service to our customers in North America."

Adds Raman Mehta, CEO of Alchem International, "Our goal is to build long-term supplier relations with manufacturers that, like Alchem, are dedicated to quality and that share our passion to help consumers live a healthy life. Alchem is improving the bioavailability of well-known dietary supplement ingredients, such as silymarin and curcumin, via proprietary technology and is developing new proprietary topical blends for the cosmetics industry."

"We are already seeing an increased demand for our vinpocetine, a new ingredient launch in 2011," continues Leduc. "Vinpocetine is used as a drug for memory enhancement in many countries, and is sold as a dietary supplement in the U.S. Alchem's pharmaceutical-grade vinpocetine is naturally-derived, and is produced in our state-of-the-art facility inspected by the U.S. FDA with zero 493s. Further, it meets European Pharmacopoeia standards."

For further information, please contact:

Laurent Leduc, COO Alchem USA Inc., Tel: +1-952-933-3822, Cell: +1-612-802-6124, laurent@alcheminternational.com

http://www.alcheminternational.com


'/>"/>
SOURCE Alchem International Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. P Summit calls for a new alchemy around phosphorus and food
2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
5. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
6. PAREXEL International to Present at J.P. Morgan Healthcare Conference
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. International Attendance for Networking and Education at Informex Beyond Manufacturing
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... 22, 2017 , ... RURO, Inc., a leading LIMS, RFID, ... content-packed update to the Limfinity® framework. , LimitLIS® and other RURO solutions based ... of customers among labs and other businesses. Limfinity® 6.5 adds new features and ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadyl™, the ...
(Date:6/19/2017)... ... June 19, 2017 , ... ... clinical development reported today that it is launching two new additions of its ... be demonstrating new capabilities at the DIA 2017 Annual Meeting in Chicago, IL, ...
(Date:6/16/2017)... ... June 16, 2017 , ... CTNext , Connecticut’s ... Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. , Nine finalists, ... a panel of judges for an opportunity to secure $10,000 awards to help support ...
Breaking Biology Technology:
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):